Advertisement
News
Subscribe to MDT Magazine News

IOF Committee of Scientific Advisors announces six new members

March 8, 2011 12:34 am | by International Osteoporosis Foundation | Comments

Includes two newly elected members from the Middle-East & Africa region

TOPICS:

IME & Elta Systems to develop TSV silicon interposers for Power Amplifier applications

March 7, 2011 10:35 pm | by I-Micronews | Comments

Enables smaller, faster, lighter and more thermally-efficient multi-chip modules for high performance wireless applications.

March of Dimes provides $2.4 million in new funding for preterm birth research

March 7, 2011 8:34 pm | by EurekAlert | Comments

(March of Dimes Foundation) The work of five researchers will be supported for the next three years by new March of Dimes Prematurity Research Initiative grants. The nearly $2.4 million in new grants is being given out by the March of Dimes to support scientific efforts to predict and...

TOPICS:
Advertisement

"Gastric Pacemaker" Fakes Fullness as You Eat

March 7, 2011 7:35 pm | by Massachusetts Institute of Technology | Comments

Implant could be an alternative to gastric bypass surgery.

TOPICS:

Making Genome Sequencing Part of Clinical Care

March 7, 2011 7:33 pm | by Massachusetts Institute of Technology | Comments

A new program takes the research out of genomics.

TOPICS:

IPC 4Q profit rises 31 pct on boost in patients

March 7, 2011 12:45 pm | by The Associated Press | Comments

IPC The Hospitalist Company Inc., a provider of in-hospital medical services, said Monday that its fourth-quarter profit rose 31 percent on a boost in patients.Profit rose to $7 million, or 42 cents per share, compared with $5.4 million, or 32 cents per share, a year ago. Revenue grew 18...

Reportlinker Adds Proteomics - Technologies, Markets and Companies

March 7, 2011 11:35 am | by Bio-Medicine.Org | Comments

NEW YORK, March 7, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Proteomics - Technologies, Markets and Companies http://www.reportlinker.com/p0203550/Proteomics---Technologies-Markets-and-Companies.html Summary This report describes...

TOPICS:

Reportlinker Adds Gene Therapy - Technologies, Markets and Companies

March 7, 2011 11:34 am | by Bio-Medicine.Org | Comments

NEW YORK, March 7, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Gene Therapy - technologies, markets and companies http://www.reportlinker.com/p0203543/Gene-Therapy---technologies-markets-and-companies.html Summary Gene therapy can be...

TOPICS:
Advertisement

Humana CEO sees 2010 compensation slide 6 percent

March 7, 2011 10:45 am | by TOM MURPHY - AP Business Writer - Associated Press | Comments

Health insurer Humana Inc. paid Chairman and CEO Michael B. McCallister 6 percent less last year than in 2009, as a decline in option awards outweighed a bump up in the long-standing executive's performance-related bonus.McCallister, 58, received 2010 compensation valued at $6.1 million from...

NIH study examines best time for healthy HIV-infected people to begin antiretrovirals

March 7, 2011 10:38 am | by EurekAlert | Comments

(NIH/National Institute of Allergy and Infectious Diseases) A major new clinical trial seeks to determine whether HIV-infected asymptomatic individuals have less risk of developing AIDS or other serious illness if they begin taking antiretrovirals sooner rather than later, based on...

TOPICS:

Psoriasis medication rises hope in the fight against multiple sclerosis

March 7, 2011 9:37 am | by EurekAlert | Comments

(Ruhr-University Bochum) Fumaric acid salts have been in use against severe psoriasis for a long time. About ten years ago, researchers in Bochum speculated that they may also have a favorable effect on multiple sclerosis as a result of their TH2 polarizing mechanisms. In parallel...

TOPICS:

Genzyme seeks shareholder OK on Sanofi deal

March 7, 2011 9:37 am | by Mass High Tech: The Journal of New England Technology | Comments

Genzyme Corp. said its board of directors unanimously recommends that shareholders accept the Sanofi-aventis revised tender offer to purchase all outstanding shares of Genzyme common stock for $74 and one contingent value right, per share.

Capacity expansion at OSRAM Opto Semiconductors

March 7, 2011 9:37 am | by I-Micronews | Comments

Conversion and expansion of chip manufacture at the Penang and Regensburg plants.

6? wafer capability for CPV solar applications

March 7, 2011 9:37 am | by I-Micronews | Comments

IQE are being recognised for developing epitaxial processes for producing high efficiency, triple junction concentrator photovoltaic (CPV) solar cells with comparable results on both 6 inch diameter germanium (Ge) and gallium arsenide (GaAs) substrates.

Repligen returns disappointing bipolar drug trial results

March 7, 2011 9:36 am | by Mass High Tech: The Journal of New England Technology | Comments

Repligen Corp. has announced its Phase 2b clinical trial results of a bipolar depression drug candidate, and the results for RG2417 did not show significant improvement in patients with bipolar depression.

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading